Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 849Carcinoma, Non-Small-Cell Lung 555Neoplasms 513Prostatic Neoplasms 504Lung Neoplasms 313Colorectal Neoplasms 309Multiple Myeloma 291Neoplasm Metastasis 252Melanoma 243Ovarian Neoplasms 215Leukemia, Myeloid, Acute 210Pancreatic Neoplasms 206Squamous Cell Carcinoma of Head and Neck 172Carcinoma, Renal Cell 166Stomach Neoplasms 161Carcinoma, Hepatocellular 160Recurrence 158Lymphoma 156Brain Neoplasms 150Glioblastoma 148Uterine Cervical Neoplasms 143Head and Neck Neoplasms 141Lymphoma, Non-Hodgkin 140Triple Negative Breast Neoplasms 137Urinary Bladder Neoplasms 136Leukemia, Lymphocytic, Chronic, B-Cell 136Precursor Cell Lymphoblastic Leukemia-Lymphoma 131Colonic Neoplasms 117Hematologic Neoplasms 116Lymphoma, Follicular 113

Interventions

Tramadol 1Oxycodone 1Hydrocodone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Intra-abdominal Cancer × Clear all
NCT06232577 2026-05-14

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
170 enrolled

Intra-abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡